Form 10-K Wave Life Sciences Ltd. For: Dec 31

Go back to Form 10-K Wave Life Sciences Ltd. For: Dec 31

RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'

March 6, 2024 4:18 PM EST

RBC Capital analyst Luca Issi reiterated a Sector Perform rating and $5.00 price target on WAVE Life Sciences (NASDAQ: WVE).

The analyst comments "Next data is HD in Q2 and 20% allele specific KD is the bogey for a go/no-go decision and TAK... More